Clinical Trials Logo

Clinical Trial Summary

Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic acid, which is a food additive that is similar to alcohol. Research suggests that octanoic acid may reduce tremor in the hands/arms with few side effects and no intoxication effects. This study will determine whether octanoic acid may be useful for reducing tremor when it affects the voice. Researchers are hypothesizing that octanoic acid will reduce the effects of tremor on the voice.


Clinical Trial Description

Background:

- Essential tremor of the voice produces regular shaking and hoarseness in the voice, making it difficult speech difficult to understand

- Several previous studies have found that octanoic acid and octanol, which are related to alcohol, can improve tremor in some people without producing many side effects and without producing intoxication

- Researchers are interested in determining whether octanoic acid can improve tremor that affects the voice

Objectives:

- To determine the effects of octanoic voice using voice recordings and listener ratings of voice

- To determine the effects of octanoic acid on level of voice disability experienced by people with essential voice tremor ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01864525
Study type Interventional
Source Syracuse University
Contact
Status Completed
Phase Phase 1/Phase 2
Start date July 2013
Completion date March 31, 2017

See also
  Status Clinical Trial Phase
Completed NCT02111369 - Propranolol and Botulinum Toxin for Essential Vocal Tremor Phase 4
Completed NCT01961297 - Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response Phase 2
Recruiting NCT03042975 - Imaging Genetics of Laryngeal Dystonia
Active, not recruiting NCT03292458 - Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor Phase 2/Phase 3